Pages that link to "Q45963202"

The following pages link to Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. (Q45963202):

Displaying 38 items.

• The neurobiology of anhedonia and other reward-related deficits (Q26853518) (← links)
• Nicotine and endogenous opioids: Neurochemical and pharmacological evidence (Q28111990) (← links)
• Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion (Q28264062) (← links)
• Removing obstacles in neuroscience drug discovery: the future path for animal models (Q28755229) (← links)
• Negative affective states and cognitive impairments in nicotine dependence (Q30371220) (← links)
• Don't stress about CRF: assessing the translational failures of CRF1antagonists (Q30399543) (← links)
• Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal (Q30448787) (← links)
• Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits (Q30480193) (← links)
• Effects of treatment for tobacco dependence on resting cerebral glucose metabolism (Q33620732) (← links)
• Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. (Q33738559) (← links)
• Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking (Q33759622) (← links)
• Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence (Q33816462) (← links)
• Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study (Q34054242) (← links)
• Reconsidering anhedonia in depression: lessons from translational neuroscience (Q34124371) (← links)
• Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics (Q34157674) (← links)
• Smoking-induced change in intrasynaptic dopamine concentration: Effect of treatment for Tobacco Dependence (Q34164210) (← links)
• Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls (Q34186224) (← links)
• Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm (Q34425063) (← links)
• Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats (Q34696292) (← links)
• Bupropion-varenicline interactions and nicotine self-administration behavior in rats (Q35091751) (← links)
• Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies (Q35694111) (← links)
• Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area (Q36122868) (← links)
• Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. (Q36323545) (← links)
• Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse (Q36349942) (← links)
• The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. (Q36755071) (← links)
• Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation (Q36851620) (← links)
• Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment (Q37353350) (← links)
• Varenicline in smoking cessation (Q37762828) (← links)
• The effects of nicotine and cigarette smoke on the monoamine transporters (Q37838857) (← links)
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition (Q38260259) (← links)
• The role of mesoaccumbens dopamine in nicotine dependence (Q38338790) (← links)
• Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications (Q38338793) (← links)
• Combination bupropion SR and varenicline for smoking cessation: a systematic review (Q38711234) (← links)
• Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats. (Q39572734) (← links)
• Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats. (Q41012076) (← links)
• Performance and thermoregulatory effects of chronic bupropion administration in the heat (Q46251996) (← links)
• Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm (Q50061654) (← links)
• Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats (Q89122894) (← links)